Biodexa Pharmaceuticals (BDRX) Goodwill (2017 - 2022)

Biodexa Pharmaceuticals (BDRX) posted Goodwill of $1.3 million for Q2 2022, down 57.71% sequentially from $3.0 million in Q4 2019.

Biodexa Pharmaceuticals (BDRX) Goodwill (2017 - 2022) Analysis & Trends

Biodexa Pharmaceuticals has reported Goodwill for 4 years, with the latest figure at $1.3 million in Q2 2022.

Quarterly Goodwill changed N/A year-over-year to $1.3 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $1.3 million (changed N/A YoY) and the FY2019 annual result came in at $2.9 million, down 4.4% from the prior year.
Goodwill retreated to $1.3 million in Q2 2022 per BDRX's latest filing, from $3.0 million in the prior quarter.
Over five years, Goodwill peaked at $9.1 million in Q2 2018 and troughed at $1.3 million in Q2 2022.
A 3-year average of $4.1 million and a median of $3.0 million in 2019 frame the typical range for Goodwill.
The sharpest annual moves came in 2018 and 2019: Goodwill sank 83.36% in 2018, then retreated 0.08% in 2019.
Over 3 years, Goodwill stood at $3.0 million in 2018, then slipped by 0.08% to $3.0 million in 2019, then slumped by 57.71% to $1.3 million in 2022.
According to Business Quant data, Goodwill over the past three periods registered $1.3 million, $3.0 million, and $3.0 million for Q2 2022, Q4 2019, and Q4 2018 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Biodexa Pharmaceuticals	63,168.17	-11.29 Mn	-

Download Data